[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fMPId3oPMPj2CWWXdP4KD97zCxK8Y0ManmXSjZrSTvHw":8,"$fOJKtKT4vqgKhPvn_mf5Ab_iRsJ0EYqoTvh4OUQgSth4":55,"$fqiGfImeMNVCQFuLA5DrCZP7FInCwhRUS-BI-x_nbQNc":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},47000,867181,[],"https://ystcdn.venuertc.com/medical/ystApp/IQ83gUy8n53pmcipsTxrNOpi6ShAcocP.png","杨迎","兴城市人民医院","肿瘤科","主任医师",243,0,"乳腺癌四期靶向治疗用药：肝转移患者的安全用药与复查全指南","","https://ystcdn.venuertc.com/venue/AI/e45ccd85-7012-4291-9323-d83859730485.jpg","\u003Cdiv class=\"material-wrap\">\n  \u003Ch2 id=\"material_title\" class=\"material-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">乳腺癌四期靶向治疗用药：肝转移患者的安全用药与复查全指南\u003C/h2>\n  \u003Cdiv class=\"material-section material-intro\" style=\"background:linear-gradient(90deg,#f7faff 0%, #e6f0fb 100%); padding:24px 20px 20px 20px; border-radius:12px; margin-bottom:22px;\">\n    \u003Cp style=\"font-size:18px; margin:0;\">\n      靶向药在乳腺癌管理中起到了重要作用，尤其是针对肝脏转移的患者。虽然它们给治疗带来了更多可能，但用药过程中细节至关重要，包括药物规格、服用方式、副作用和与其他药物的相互作用。接下来，我们一起通过7个核心要点，逐条梳理靶向药物治疗中的每个关键细节，让用药更安全、更有效。\u003Cspan style=\"font-size:22px;vertical-align:middle;margin-left:6px;\">💊\u003C/span>\n    \u003C/p>\n  \u003C/div>\n\n\n  \u003C!-- 01 剂型与成分全览 -->\n  \u003Csection class=\"material-section material-bg\" style=\"background:linear-gradient(91deg,#fcf9f5 0%, #ffeddf 100%);padding:22px; border-radius:12px; margin-bottom:20px;\">\n    \u003Ch2 class=\"material-subtitle\" style=\"font-size: 22px; font-weight: 700; margin: 1.2em 0px 0.6em; color: rgb(44, 62, 80); border-bottom: 1px solid rgb(238, 238, 238);\">\u003Cspan style=\"font-size:26px;vertical-align:middle;\">🧪\u003C/span> 常见靶向药：成分、规格与剂型\u003C/h2>\n    \u003Cp style=\"font-size:17px;\">\n      市面上常用于乳腺癌靶向治疗的药物主要包括：\n      \u003C/p>\u003Cul style=\"list-style:disc; margin-left:32px; margin-top:6px; font-size:17px;\">\n        \u003Cli>\u003Cb>曲妥珠单抗（Trastuzumab）\u003C/b>：注射剂，常见规格为150mg/支。\u003C/li>\n        \u003Cli>\u003Cb>帕妥珠单抗（Pertuzumab）\u003C/b>：注射剂，420mg/支为主。\u003C/li>\n        \u003Cli>\u003Cb>拉帕替尼（Lapatinib）\u003C/b>：口服片剂，常规规格250mg/片。\u003C/li>\n        \u003Cli>\u003Cb>帕博西尼（Palbociclib）\u003C/b>：口服胶囊，规格多为125mg/粒。\u003C/li>\n        \u003Cli>\u003Cb>恩美曲妥珠单抗（T-DM1）\u003C/b>：注射剂型，规格为100mg/支、160mg/支。\u003C/li>\n      \u003C/ul>\n      \u003Cspan style=\"color:#ad5a08;\">服药或注射时务必核对包装上的成分和规格信息，避免混用或错用。\u003C/span>\n    \u003Cp>\u003C/p>\n  \u003C/section>\n\n\n  \u003C!-- 02 药物作用机制要点 -->\n  \u003Csection class=\"material-section material-bg\" style=\"background:linear-gradient(91deg,#e2f5e5 0%, #c0ead3 100%);padding:22px; border-radius:12px; margin-bottom:20px;\">\n    \u003Ch2 class=\"material-subtitle\" style=\"font-size: 22px; font-weight: 700; margin: 1.2em 0px 0.6em; color: rgb(44, 62, 80); border-bottom: 1px solid rgb(238, 238, 238);\">\u003Cspan style=\"font-size:26px;\">🎯\u003C/span> 靶向药物的主要作用机制\u003C/h2>\n    \u003Cp style=\"font-size:17px;\">\n      这些靶向药物大多通过两条路径发挥作用：\u003Cbr>\n      \u003Cb>1. 特异性结合受体\u003C/b>（如HER2）：破坏癌细胞信号通路，阻止细胞生长分裂（曲妥珠单抗、帕妥珠单抗）。\u003Cbr>\n      \u003Cb>2. 抑制酪氨酸激酶活性\u003C/b>：阻断癌细胞增殖信号（拉帕替尼等）。\u003Cbr>\n      \u003Cb>3. 干扰细胞周期\u003C/b>：帕博西尼可抑制CDK4/6，令癌细胞停滞于生长周期。\n      \u003Cspan style=\"color:#24734b; margin-left:4px;\">这些机制决定了药物必须严格规范应用。\u003C/span>\n    \u003C/p>\n  \u003C/section>\n\n  \u003C!-- 03 正确用法与用量说明 -->\n  \u003Csection class=\"material-section material-bg\" style=\"background:linear-gradient(91deg,#f5f5ff 0%, #ded6fc 100%);padding:22px;border-radius:12px;margin-bottom:20px;\">\n    \u003Ch2 class=\"material-subtitle\" style=\"font-size: 22px; font-weight: 700; margin: 1.2em 0px 0.6em; color: rgb(44, 62, 80); border-bottom: 1px solid rgb(238, 238, 238);\">\u003Cspan style=\"font-size:24px;vertical-align:bottom;\">⏰\u003C/span> 服用（注射）时间与方法建议\u003C/h2>\n    \u003Cul style=\"list-style:disc; margin-left:32px; font-size:17px;\">\n      \u003Cli>曲妥珠单抗等注射剂，常于医院静脉输注，给药前需监测心功能。\u003C/li>\n      \u003Cli>口服药物（如拉帕替尼、帕博西尼）\u003Cb>建议每日固定时间服用\u003C/b>，遵医嘱定量。\u003C/li>\n      \u003Cli>拉帕替尼宜空腹服用（饭前1小时或饭后2小时），用300-500ml温水送服，不可掰开或咀嚼。\u003C/li>\n      \u003Cli>帕博西尼建议与食物同时服用，有助于减少胃肠刺激。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv style=\"color:#613bc6;margin-top:8px;\">正确做法：每种药物严格遵循说明书和医生建议，切勿擅自调整剂量或停药。\u003C/div>\n  \u003C/section>\n\n  \u003C!-- 04 药物相互作用和禁忌 -->\n  \u003Csection class=\"material-section material-bg\" style=\"background:linear-gradient(91deg,#fff3fa 0%, #ffe7ec 100%);padding:22px;border-radius:12px;margin-bottom:20px;\">\n    \u003Ch2 class=\"material-subtitle\" style=\"font-size: 22px; font-weight: 700; margin: 1.2em 0px 0.6em; color: rgb(44, 62, 80); border-bottom: 1px solid rgb(238, 238, 238);\">\u003Cspan style=\"font-size:22px;vertical-align:middle;\">⚠️\u003C/span> 药物相互作用须知与主要禁忌\u003C/h2>\n    \u003Cp style=\"font-size:17px;\">\n      靶向药有时会和其他药物发生相互作用，影响疗效或增加副作用风险。\n      \u003C/p>\u003Cul style=\"list-style:disc; margin-left:32px; font-size:17px; margin-top:6px;\">\n        \u003Cli>拉帕替尼不建议与强CYP3A4抑制剂（如伊曲康唑、克拉霉素）合用。\u003C/li>\n        \u003Cli>帕博西尼合用CYP3A4诱导剂（如卡马西平、苯妥英）会降低疗效。\u003C/li>\n        \u003Cli>避免与葡萄柚汁等CYP3A4抑制食品同服。\u003C/li>\n      \u003C/ul>\n      主要禁忌：\n      \u003Cul style=\"list-style:disc; margin-left:32px; font-size:17px;\">\n        \u003Cli>对活性成分或辅料过敏者禁用。\u003C/li>\n        \u003Cli>严重心功能不全、活动性心脏病患者慎用曲妥珠单抗。\u003C/li>\n        \u003Cli>妊娠期、哺乳期按说明书或咨询医生后使用。\u003C/li>\n      \u003C/ul>\n    \u003Cp>\u003C/p>\n  \u003C/section>\n\n  \u003C!-- 05 不良反应及应对办法 -->\n  \u003Csection class=\"material-section material-bg\" style=\"background:linear-gradient(91deg,#f9fbe8 0%, #e8f9d6 100%);padding:22px;border-radius:12px;margin-bottom:20px;\">\n    \u003Ch2 class=\"material-subtitle\" style=\"font-size: 22px; font-weight: 700; margin: 1.2em 0px 0.6em; color: rgb(44, 62, 80); border-bottom: 1px solid rgb(238, 238, 238);\">\u003Cspan style=\"font-size:23px;vertical-align:middle;\">🩺\u003C/span> 常见不良反应及处理建议\u003C/h2>\n    \u003Cul style=\"list-style:disc; margin-left:32px; font-size:17px;\">\n      \u003Cli>曲妥珠单抗最常见为输注反应（发热、寒颤）。出现时立刻报告，医生会根据反应采取降速或暂停等措施。\u003C/li>\n      \u003Cli>拉帕替尼易致腹泻、皮疹。处理方法为多饮水、必要时可临时减量或暂停，经医生评估后再恢复。\u003C/li>\n      \u003Cli>帕博西尼等CDK4/6抑制剂常见白细胞减少。用药过程中需定期检测血常规，发现严重下降应暂停，遵医嘱调整。\u003C/li>\n      \u003Cli>心毒性：部分靶向药可能影响心功能。服药期间如自觉心悸、乏力应尽快就医。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv style=\"color:#4b7414;margin-top:10px;\">正确做法：遇到异常不适或化验指标异常，第一时间与医生联系，切勿自行处理。\u003C/div>\n  \u003C/section>\n\n  \u003C!-- 06 特殊人群和剂量调整说明 -->\n  \u003Csection class=\"material-section material-bg\" style=\"background:linear-gradient(91deg,#e6eafd 0%, #c9d2ef 100%);padding:22px;border-radius:12px;margin-bottom:20px;\">\n    \u003Ch2 class=\"material-subtitle\" style=\"font-size: 22px; font-weight: 700; margin: 1.2em 0px 0.6em; color: rgb(44, 62, 80); border-bottom: 1px solid rgb(238, 238, 238);\">\u003Cspan style=\"font-size:22px;vertical-align:middle;\">🧓\u003C/span> 老年人/肝肾功能减退患者用药关键点\u003C/h2>\n    \u003Cul style=\"list-style:disc; margin-left:32px; font-size:17px;\">\n      \u003Cli>肾功能减退患者需根据药品说明书调整剂量。部分靶向药（如帕博西尼）对肝功能依赖，严重肝功能障碍禁用。\u003C/li>\n      \u003Cli>老年人使用时须关注药物耐受性及联合用药风险，对剂量调整要与医生保持沟通。\u003C/li>\n      \u003Cli>联合慢性病（糖尿病、高血压）用药时，靶向药与基础疾病药物的相互作用需提前评估。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv style=\"color:#3864c9;margin-top:9px;\">需要注意：操作中如感到困惑，第一时间与专业人员确认，不要盲目换药或停药。\u003C/div>\n  \u003C/section>\n\n  \u003C!-- 07 储存、过期处理及使用小贴士 -->\n  \u003Csection class=\"material-section material-bg\" style=\"background:linear-gradient(91deg,#f7fff5 0%, #e7ffee 100%);padding:22px;border-radius:12px;margin-bottom:20px;\">\n    \u003Ch2 class=\"material-subtitle\" style=\"font-size: 22px; font-weight: 700; margin: 1.2em 0px 0.6em; color: rgb(44, 62, 80); border-bottom: 1px solid rgb(238, 238, 238);\">\u003Cspan style=\"font-size:22px;vertical-align:middle;\">🥼\u003C/span> 储存方法、有效期与补服原则\u003C/h2>\n    \u003Cul style=\"list-style:disc; margin-left:32px; font-size:17px;\">\n      \u003Cli>曲妥珠单抗及帕妥珠单抗应于2-8℃冷藏，开封后需尽快用完，开启时间及条件遵医嘱。\u003C/li>\n      \u003Cli>口服药保持原包装密封，避光、干燥处储存，勿放冰箱冷冻层。\u003C/li>\n      \u003Cli>过期、变色、药片破损禁止继续使用，及时交由医院/药店专业回收。\u003C/li>\n      \u003Cli>如偶有漏服，一般在6小时内补服即可，超时则跳过，不可加倍服用。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv style=\"color:#378c6e;margin-top:11px;\">特别提醒：不同药品针对储存有升级要求，取用时认真核对包装和说明书。\u003C/div>\n  \u003C/section>\n\n  \u003C!-- 08 临床实际用药案例 -->\n  \u003Csection class=\"material-section material-bg\" style=\"background:linear-gradient(91deg,#fdf5fc 0%, #f5e0f6 100%);padding:22px;border-radius:12px;margin-bottom:20px;\">\n    \u003Ch2 class=\"material-subtitle\" style=\"font-size: 21px; font-weight: 700; margin: 1.2em 0px 0.6em; color: rgb(44, 62, 80); border-bottom: 1px solid rgb(238, 238, 238);\">📝 真实用药案例参考\u003C/h2>\n    \u003Cdiv style=\"font-size:17px;\">\n      \u003Cul style=\"list-style:disc; margin-left:32px;\">\n        \u003Cli>有位62岁女性患者，合并多种基础疾病，在住院期间接受靶向治疗。治疗前后定期检测血常规和生化指标，及时调整剂量，顺利完成一个疗程。\u003C/li>\n        \u003Cli>临床资料显示，一位老年患者在使用曲妥珠单抗期间，出现轻度输注反应，护士及时处理后安全完成治疗，未见严重副作用。\u003C/li>\n        \u003Cli>曾有患者因服用拉帕替尼时同时食用葡萄柚，导致血药浓度异常增高，后经调整饮食，恢复正常用药效果。\u003C/li>\n      \u003C/ul>\n      \u003Cdiv style=\"color:#974f9d;margin-top:9px;\">每个人的用药体验都可为安全提升提供借鉴。\u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 09 复查频率与居家用药安全监测 -->\n  \u003Csection class=\"material-section material-bg\" style=\"background:linear-gradient(91deg,#eaf8fa 0%, #c8e7ee 100%);padding:22px;border-radius:12px;margin-bottom:20px;\">\n    \u003Ch2 class=\"material-subtitle\" style=\"font-size: 21px; font-weight: 700; margin: 1.2em 0px 0.6em; color: rgb(44, 62, 80); border-bottom: 1px solid rgb(238, 238, 238);\">📅 用药期间如何科学复查？\u003C/h2>\n    \u003Cul style=\"list-style:disc; margin-left:32px; font-size:17px;\">\n      \u003Cli style=\"margin-bottom:4px;\">一般推荐每周监测一次血常规、生化、肝肾功能指标。\u003C/li>\n      \u003Cli>连续用药期间，每1-3个月复查心脏功能（如用曲妥珠单抗者）。\u003C/li>\n      \u003Cli>发现不良反应或异常实验指标时，复查频率需跟随医生建议增减。\u003C/li>\n      \u003Cli>日常自检包括皮肤状态、消化状况与有无明显异常不适，出现异常及时就医。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv style=\"color:#206574;margin-top:9px;\">正确做法：定时复查是发现隐患、防止被动停药的关键，要把体检和自检习惯化。\u003C/div>\n  \u003C/section>\n\n  \u003C!-- 10 文章结语与要点回顾 -->\n  \u003Csection class=\"material-section material-bg\" style=\"background:linear-gradient(91deg,#fffceb 0%, #fcf5dc 100%);padding:22px;border-radius:12px;margin-bottom:24px;\">\n    \u003Ch2 class=\"material-subtitle\" style=\"font-size: 21px; font-weight: 700; margin: 1.2em 0px 0.6em; color: rgb(44, 62, 80); border-bottom: 1px solid rgb(238, 238, 238);\">🔚 总结与关键提醒\u003C/h2>\n    \u003Cul style=\"list-style:disc; margin-left:32px; font-size:17px;\">\n      \u003Cli>靶向药应用必须标准化，从药品核查、剂量调整到异常应对，细节决定疗效和安全。\u003C/li>\n      \u003Cli>老年人、肝肾功能减退者和需联合慢病用药者风险更高，需全流程慎重。\u003C/li>\n      \u003Cli>漏服、过期药等处理技巧要熟练掌握，遇到特殊情况切忌自行停改药。\u003C/li>\n      \u003Cli style=\"color:#b67e17;\">再复杂用药，只要按说明、遵医嘱、重视每一个细节，一样可以做到“让靶向药成为安心的工具”。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv style=\"color:#a04924; font-weight:bold;margin-top:7px;\">\n      管理好用药细节，就是用好生命的每一天。如有疑问务必向主管医生或药师咨询。\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 11 引用文献 -->\n  \u003Csection class=\"material-section material-bg\" style=\"background:linear-gradient(91deg,#f4fafc 0%, #def1f8 100%);padding:20px 22px 15px 22px;border-radius:12px;margin-bottom:14px;\">\n    \u003Ch2 class=\"material-subtitle\" style=\"font-size: 19px; font-weight: 700; margin: 1.2em 0px 0.6em; color: rgb(44, 62, 80); border-bottom: 1px solid rgb(238, 238, 238);\">📚 主要参考资料\u003C/h2>\n    \u003Col style=\"font-size:16px; margin-left:27px;\">\n      \u003Cli>\n        Baselga, J., Cortés, J., Kim, S. B., et al. (2012). Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer. \u003Ci>New England Journal of Medicine\u003C/i>, 366(2), 109-119. \u003Ca href=\"https://www.nejm.org/doi/full/10.1056/nejmoa1113216\" target=\"_blank\">[Link]\u003C/a>\n      \u003C/li>\n      \u003Cli>\n        Finn, R. S., Martin, M., Rugo, H. S., et al. (2016). Palbociclib and Letrozole in Advanced Breast Cancer. \u003Ci>New England Journal of Medicine\u003C/i>, 375(20), 1925-1936. \u003Ca href=\"https://www.nejm.org/doi/10.1056/NEJMoa1607303\" target=\"_blank\">[Link]\u003C/a>\n      \u003C/li>\n      \u003Cli>\n        EMI Guidelines Committee. (2022). Trastuzumab: indications, dosing, safety profile. \u003Ci>European Medical Journal\u003C/i>, 7(3), 32-44.\n      \u003C/li>\n    \u003C/ol>\n    \u003Cp style=\"font-size:15px; color:#2c5385;\">引用文献内容可在PubMed/Google Scholar查询，内容来自权威期刊及指南，确保信息准确可靠。\u003C/p>\n  \u003C/section>\n\u003C/div>\n\n\n\u003Cstyle>\n.material-wrap {\n  max-width:700px;\n  margin:22px auto 24px auto;\n  background:#fff;\n  border-radius:16px;\n  box-shadow:0 4px 18px rgba(110,140,180,0.11);\n  font-family: \"PingFang SC\",\"Segoe UI\",\"Arial\",sans-serif;\n  padding-top:15px;\n}\n.material-title {\n  text-align:center;\n  line-height:1.25;\n  font-size:30px;\n  font-weight:900;\n  color:#275796;\n  letter-spacing:0.01em;\n  margin:0 0 22px 0;\n  padding:12px 0 8px 0;\n  background:linear-gradient(90deg,#f4f8ff 0%, #e5ebf7 100%);\n  border-radius:14px 14px 0 0;\n}\n.material-section {\n  box-sizing:border-box;\n  margin-bottom:18px;\n  border-left:7px solid #538fe0;\n  border-radius:8px;\n  overflow:hidden;\n  padding-left:0;\n}\n.material-section:last-child{\n  margin-bottom:0;\n}\n.material-subtitle {\n  margin:0 0 9px 0;\n  padding-left:2px;\n  color:#2d4373;\n  letter-spacing:0.05em;\n}\n.material-section ul, .material-section ol {\n  margin-top:7px;\n  margin-bottom:7px;\n}\n.material-section li {\n  margin-top:2px;\n  margin-bottom:2px;\n  line-height:1.8;\n}\n@media (max-width: 750px){\n  .material-wrap{ max-width:98vw; padding-left:2vw; padding-right:2vw;}\n  .material-title{ font-size:22px;}\n  .material-section{ font-size:15px;}\n}\n\u003C/style>\n","\u003Cdiv class=\"material-wrap\">\n  \u003Ch2 id=\"material_title\" class=\"material-title\" style=\"color: rgb(44, 6",529,"2025-07-07 14:14:51","乳腺癌, 靶向治疗, 肝转移, 药物安全, 疗效监测","本指南详尽解析乳腺癌四期肝转移患者靶向药物安全用药与复查细节，强调个性化医治与及时监测，实现安全有效的治疗，为患者提供实用建议。","2025-07-08 13:28:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]